申请人:Neurocrine Biosciences, Inc.
公开号:US08084614B2
公开(公告)日:2011-12-27
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure, wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
本发明公开了GnRH受体拮抗剂,其在男性和女性的多种与性激素相关的疾病治疗中具有用途。本发明的化合物具有以下结构,其中R1a,R1b,R1c,R1d,R2,R2a和A的定义如本文中所述,包括立体异构体,酯类,溶剂化物和其药学上可接受的盐。本发明还公开了含有本发明化合物与药学上可接受的载体的组合物,以及与其相关的用于在需要时抗agonadotropin-releasing hormone的方法。